Webinar: Introduction to the Food and Drugs Act Liaison Office and an Overview of the Reconsideration Process
MARK YOUR CALENDARS for Thursday, April 28th; 1:00 pm - 2:00 pm, and share this news with your colleagues!
Topic: Introduction to the Food and Drugs Act Liaison Office and an Overview of the Reconsideration Process.
Overview: The Food and Drugs Act Liaison Office (FDALO) is a resource for individuals, business and organizations when they experience problems with how Health Canada administers the Food and Drugs Act.
The presentation covers FDALO’s services and how they may be of use to you. It includes a brief overview of the reconsideration process for human drugs and natural health products. The reconsideration process is a non-adversarial dispute resolution process to ensure that decisions about a specific submission were made correctly, and in keeping with existing scientific standards and regulations.
Following the presentation, there will be time for questions and answers.
*Registrants may be substituted, but no refunds will be issued after the deadline.
*Disclaimer: CAPRA reserves the right to make amendments to the conference (including but not limited to speakers' identity, topics, locations, the timing of speakers) without notice to you. If the conference is cancelled for any reason whatsoever, such reason not within the control of CAPRA, CAPRA shall not be liable for any cost or loss otherwise incurred.
Event Registration Form: Please add your First name, Last name and the Email address that you will use to log in the day of the webinar.
Be sure to check system requirements to avoid any connection issues the day of the event.
In case of unexpected interruptions such as a power outage please log back, and the webinar will restart from where it was disconnected.
Speakers / Panelists
-
Derrick Barnes
Director at the Food and Drugs Act Liaison Office (FDALO)
Derrick Barnes
Director at the Food and Drugs Act Liaison Office (FDALO)
Derrick is a trained conflict resolution practitioner and Registered Social Worker. He joined the Food and Drugs Act Liaison Office (FDALO) as a Senior Advisor in 2008. Since then, he has worked closely with Health Canada staff and external stakeholders to promote an open and transparent regulatory system. He has been actively involved with reconsideration processes, outreach and case management within the office. Derrick was appointed Director of the Office in November 2021.
-
Merryl Ndema-Moussa
Acting Senior Advisor at the Food and Drugs Act Liaison Office (FDALO)
Merryl Ndema-Moussa
Acting Senior Advisor at the Food and Drugs Act Liaison Office (FDALO)
Merryl Ndema-Moussa is an Acting Senior Advisor at the Food and Drugs Act Liaison Office. He has been with the team since 2018 and oversees the reconsideration process as well as other conflict management and training components of the office.
Registration is now closed